Cargando…
Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
This review identifies possible pharmacological targets for inflammatory bowel disease (IBD) within the IL-23/IL-17 axis. Specifically, there are several targets within the IL-23/IL-17 pathways for potential pharmacological intervention with antibodies or small molecule inhibitors. These targets inc...
Autor principal: | Fitzpatrick, Leo R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312283/ https://www.ncbi.nlm.nih.gov/pubmed/22506136 http://dx.doi.org/10.1155/2012/389404 |
Ejemplares similares
-
Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases
por: Bunte, Kübra, et al.
Publicado: (2019) -
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
por: Li, Na, et al.
Publicado: (2017) -
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
por: Liu, Taoming, et al.
Publicado: (2020) -
The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017) -
Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine
por: Zaph, Colby, et al.
Publicado: (2008)